Ras-association domain family protein 6 induces apoptosis via both caspase-dependent and caspase-independent pathways

被引:74
作者
Ikeda, Mitsunobu
Hirabayashi, Susumu
Fujiwara, Naoyuki
Mori, Hiroki
Kawata, Akira
Iida, Junko
Bao, Yijun
Iida, Tadatsune
Sugimura, Haruhiko
Hata, Yutaka
机构
[1] Grad Sch Med, Dept Med Biochem, Bunkyo Ku, Tokyo 1138519, Japan
[2] Hamamatsu Univ Sch Med, Dept Pathol 1, Hamamatsu, Shizuoka 4313192, Japan
关键词
apoptosis; Ras; caspase; apoptosis-inducing factor; endonuclease G; tumor necrosis factor-alpha;
D O I
10.1016/j.yexcr.2007.02.013
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Ras-association domain family (RASSF) comprises six members (RASSF1-6) that each harbors a RalGDS/AF-6 (RA) and Sav/RASSF/Hippo (SARAH) domain. The RASSF proteins are known as putative tumor suppressors but RASSF6 has not yet been studied. We have here characterized human RASSF6. Although RASSF6 has RA domain, it does not bind Ki-Ras, Ha-Ras, N-Ras, M-Ras, or TC21 under the condition that Nore1 (RASSF5) binds these Ras proteins. The message of RASSF6 is detected by RT-PCR in several cell lines including HeLa, MCF-7, U373, A549, and HepG2 cells, but the protein expression is low. The enhanced expression of RASSF6 causes apoptosis in HeLa cells. RASSF6 activates Bax and induces cytochrome C release. Caspase-3 activation is also induced, but the caspase inhibitor, Z-VAD-FMK, does not block RASSF6-mediated apoptosis. Apoptosis-inducing factor and endonuclease G are released from the mitochondria upon expression of RASSF6 and their releases are not blocked by Z-VAD-FMK. The knock down of RASSF6 partially blocks tumor necrosis factor-alpha-induced cell death in HeLa cells. These findings indicate that RASSF6 is implicated in apoptosis in HeLa cells and that it triggers both caspase-dependent and caspase-independent pathways. (c) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:1484 / 1495
页数:12
相关论文
共 34 条
[1]   Role of the ras-association domain family 1 tumor suppressor gene in human cancers [J].
Agathanggelou, A ;
Cooper, WN ;
Latif, F .
CANCER RESEARCH, 2005, 65 (09) :3497-3508
[2]   The tumor suppressor RASSF1A and MAP-1 link death receptor signaling to bax conformational change and cell death [J].
Baksh, S ;
Tommasi, S ;
Fenton, S ;
Yu, VC ;
Martins, LM ;
Pfeifer, GP ;
Latif, F ;
Downward, J ;
Neel, BG .
MOLECULAR CELL, 2005, 18 (06) :637-650
[3]   The dark side of Ras: regulation of apoptosis [J].
Cox, AD ;
Der, CJ .
ONCOGENE, 2003, 22 (56) :8999-9006
[4]   Role of AIF in caspase-dependent and caspase-independent cell death [J].
Cregan, SP ;
Dawson, VL ;
Slack, RS .
ONCOGENE, 2004, 23 (16) :2785-2796
[5]   Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3 [J].
Dammann, R ;
Li, C ;
Yoon, JH ;
Chin, PL ;
Bates, S ;
Pfeifer, GP .
NATURE GENETICS, 2000, 25 (03) :315-319
[6]   The Ste20 group kinases as regulators of MAP kinase cascades [J].
Dan, I ;
Watanabe, NM ;
Kusumi, A .
TRENDS IN CELL BIOLOGY, 2001, 11 (05) :220-230
[7]   Mammalian Sterile20-like kinase 1 and the regulation of apoptosis [J].
de Souza, PM ;
Lindsay, MA .
BIOCHEMICAL SOCIETY TRANSACTIONS, 2004, 32 :485-488
[8]   RASSF4/AD037 is a potential ras effector/tumor suppressor of the RASSF family [J].
Eckfeld, K ;
Hesson, L ;
Vos, MD ;
Bieche, I ;
Latif, F ;
Clark, GI .
CANCER RESEARCH, 2004, 64 (23) :8688-8693
[9]   A novel potential effector of M-Ras and p21 Ras negatively regulates p21 Ras-mediated gene induction and cell growth [J].
Ehrhardt, GRA ;
Korherr, C ;
Wieler, JS ;
Knaus, M ;
Schrader, JW .
ONCOGENE, 2001, 20 (02) :188-197
[10]   Dynamics of the Ras/ERK MAPK cascade as monitored by fluorescent probes [J].
Fujioka, A ;
Terai, K ;
Itoh, RE ;
Aoki, K ;
Nakamura, T ;
Kuroda, S ;
Nishida, E ;
Matsuda, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (13) :8917-8926